FDA Okays Terlipressin (Terlivaz) for Hepatorenal Syndrome
The synthetic vasopressin analogue is an injectable medication indicated for patients with hepatorenal syndrome who are experiencing rapid deterioration of kidney function (type 1 hepatorenal syndrome). FDA Approvals